Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001415889-13-001969
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-03 18:35:52
Reporting Period:
2013-10-01
Filing Date:
2013-10-03
Accepted Time:
2013-10-03 18:35:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291969 H Thomas Aasen 11085 Torreyana Road #100
San Diego CA 92121
Exec Vp, Cfo And Cbo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-01 5,000 $6.95 36,585 No 4 M Direct
Common Stock Acquisiton 2013-10-01 17,500 $1.55 54,085 No 4 M Direct
Common Stock Disposition 2013-10-01 30,000 $0.00 24,085 No 5 G Direct
Common Stock Acquisiton 2013-10-01 30,000 $0.00 30,000 No 5 G Indirect By Family Trust
Common Stock Disposition 2013-10-01 30,000 $27.87 0 No 4 S Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 5 G Direct
No 5 G Indirect By Family Trust
No 4 S Indirect By Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-10-01 5,000 $0.00 5,000 $6.95
Common Stock Stock Option (right to buy) Disposition 2013-10-01 17,500 $0.00 17,500 $1.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,000 2015-03-10 No 4 M Direct
123,471 2020-03-11 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.00 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
  3. 25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
  4. 25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.